Antidepressants in Breastfeeding Mothers

Publication Date: July 23, 2015
Last Updated: March 14, 2022


Screening for PPD

Although definitive evidence of benefit is limited, the American College of Obstetricians and Gynecologists recommends that clinicians screen patients at least once during the perinatal period for depression and anxiety symptoms using a standardized, validated tool. For the first time, a large U.S. multicenter study of screening and follow-up care for PPD in a family practice setting has shown improved maternal outcomes at 12 months. (I)



Use of Antidepressants in Breastfeeding Mothers

Authoring Organization